Menu Search
Equities

GSK plc

GSK3:BUE

GSK plc

Actions
  • Price (ARS)10,805.00
  • Today's Change-30.00 / -0.28%
  • Shares traded5.00
  • 1 Year change+159.86%
  • Beta--
Data delayed at least 20 minutes, as of Apr 24 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		GSK:LSE since
announced		Transaction
value
Aiolos Bio IncDeal completed09 Jan 202409 Jan 2024Deal completed6.22%1.40bn
Data delayed at least 20 minutes, as of Apr 25 2024 14:42 BST.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Geode Capital Management LLCas of 29 Feb 202457.74k0.00%
Altrinsic Global Advisors LLCas of 30 Jun 202253.94k0.00%
Professionals� Financial � Mutual Funds Inc.as of 30 Jun 202344.59k0.00%
Counsel Portfolio Services, Inc.as of 30 Sep 202231.24k0.00%
Matrix Capital Management Trust reg.as of 31 Dec 20225.60k0.00%
Quaestio Capital Management SGR SpAas of 31 Dec 20220.000.00%
Mackenzie Financial Corp.as of 30 Sep 20230.000.00%
Primorski Skladi ddas of 30 Jun 20230.000.00%
Credit Suisse Asset Management (Schweiz) AGas of 30 Jun 20230.000.00%
More ▼
Data from 30 Jun 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.